Graphene Oxide Ameliorates the Cognitive Impairment Through Inhibiting PI3K/Akt/mTOR Pathway to Induce Autophagy in AD Mouse Model

Overview

Journal Neurochem Res

Specialties Chemistry
Neurology

Date 2020 Nov 12

PMID 33180247

Citations 15

Authors

Fangxuan Chu

Kai Li

Xiaolin Li

Lanju Xu

Jie Huang

Zhuo Yang

Affiliations

Soon will be listed here.

Abstract

Alzheimer's disease (AD) is a neurodegenerative disease of the central nervous system characterised by cognitive impairment. Its major pathological feature is the deposition of β-amyloid (Aβ) peptide, which triggers a series of pathological cascades. Autophagy is a main pathway to eliminate abnormal aggregated proteins, and increasing autophagy represents a plausible treatment strategy against relative overproduction of neurotoxic Aβ. Graphene oxide (GO) is an emerging carbon-based nanomaterial. As a derivative of graphene with neuroprotective effects, it can effectively increase the clearance of abnormally aggregated protein. In this article, we investigated the protective function of GO in an AD mouse model. GO (30 mg/kg, intraperitoneal) was administered for 2 weeks. The results of the Morris water maze test and the novel object recognition test suggested that GO ameliorated learning and memory impairments in 5xFAD mice. The long-term potentiation and depotentiation from the perforant path to the dentate gyrus in the hippocampus were increased with GO treatment in 5xFAD mice. Furthermore, GO upregulated the expression of synapse-related proteins and increased the cell density in the hippocampus. Our results showed that GO up-regulated LC3II/LC3I and Beclin-1 and decreased p62 protein levels in 5xFAD mice. In addition, GO downregulated the PI3K/Akt/mTOR signalling pathway to induce autophagy. These results have revealed the protective potential of GO in AD.

Citing Articles

Interplay between PI3k/AKT signaling and caspase pathway in Alzheimer disease: mechanism and therapeutic implications.

Bhatia V, Vikram V, Chandel A, Rattan A Inflammopharmacology. 2025; .

PMID: 40088370 DOI: 10.1007/s10787-025-01715-z.

Network pharmacology-based mechanism analysis of dauricine on the alleviating Aβ-induced neurotoxicity in Caenorhabditis elegans.

Zhang R, Huang X, Zhou C, Zhang Q, Jia D, Xie X BMC Complement Med Ther. 2024; 24(1):321.

PMID: 39215261 PMC: 11363685. DOI: 10.1186/s12906-024-04589-w.

Transcranial Magneto-Acoustic Stimulation Protects Synaptic Rehabilitation from Amyloid-Beta Plaques via Regulation of Microglial Functions.

Zhang C, Tan R, Zhou X, Wang R, Wang X, Ma R Int J Mol Sci. 2024; 25(9).

PMID: 38731870 PMC: 11083601. DOI: 10.3390/ijms25094651.

Effects of Halloysite Nanotubes and Multi-walled Carbon Nanotubes on Kruppel-like Factor 15-Mediated Downstream Events in Mouse Hearts After Intravenous Injection.

Zhang Y, Cheng Y, Zhao W, Song F, Cao Y Cardiovasc Toxicol. 2024; 24(4):408-421.

PMID: 38411850 DOI: 10.1007/s12012-024-09844-7.

Glial Activation, Mitochondrial Imbalance, and Akt/mTOR Signaling May Be Potential Mechanisms of Cognitive Impairment in Heart Failure Mice.

Wu Y, Zhou K, Liu B, Xu J, Lei L, Hu J Neurotox Res. 2023; 41(6):589-603.

PMID: 37668877 DOI: 10.1007/s12640-023-00655-2.

References

Leinenga G, Gotz J . Scanning ultrasound removes amyloid-β and restores memory in an Alzheimer's disease mouse model. Sci Transl Med. 2015; 7(278):278ra33. DOI: 10.1126/scitranslmed.aaa2512. View

Ittner L, Gotz J . Amyloid-β and tau--a toxic pas de deux in Alzheimer's disease. Nat Rev Neurosci. 2011; 12(2):65-72. DOI: 10.1038/nrn2967. View

Reiss A, Arain H, Stecker M, Siegart N, Kasselman L . Amyloid toxicity in Alzheimer's disease. Rev Neurosci. 2018; 29(6):613-627. DOI: 10.1515/revneuro-2017-0063. View

Paquet C, Nicoll J, Love S, Mouton-Liger F, Holmes C, Hugon J . Downregulated apoptosis and autophagy after anti-Aβ immunotherapy in Alzheimer's disease. Brain Pathol. 2017; 28(5):603-610. PMC: 8028546. DOI: 10.1111/bpa.12567. View

Caccamo A, Majumder S, Richardson A, Strong R, Oddo S . Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments. J Biol Chem. 2010; 285(17):13107-20. PMC: 2857107. DOI: 10.1074/jbc.M110.100420. View

Menzies F, Fleming A, Caricasole A, Bento C, Andrews S, Ashkenazi A . Autophagy and Neurodegeneration: Pathogenic Mechanisms and Therapeutic Opportunities. Neuron. 2017; 93(5):1015-1034. DOI: 10.1016/j.neuron.2017.01.022. View

Tan C, Yu J, Tan M, Jiang T, Zhu X, Tan L . Autophagy in aging and neurodegenerative diseases: implications for pathogenesis and therapy. Neurobiol Aging. 2013; 35(5):941-57. DOI: 10.1016/j.neurobiolaging.2013.11.019. View

Cai Z, Zhao B, Li K, Zhang L, Li C, Quazi S . Mammalian target of rapamycin: a valid therapeutic target through the autophagy pathway for Alzheimer's disease?. J Neurosci Res. 2012; 90(6):1105-18. DOI: 10.1002/jnr.23011. View

Li Q, Liu Y, Sun M . Autophagy and Alzheimer's Disease. Cell Mol Neurobiol. 2016; 37(3):377-388. PMC: 11482122. DOI: 10.1007/s10571-016-0386-8. View

10.

Chen G, Chen C, Tuan H, Yuan P, Li K, Yang H . Graphene oxide triggers toll-like receptors/autophagy responses in vitro and inhibits tumor growth in vivo. Adv Healthc Mater. 2014; 3(9):1486-95. DOI: 10.1002/adhm.201300591. View

11.

Chen G, Meng C, Lin K, Tuan H, Yang H, Chen C . Graphene oxide as a chemosensitizer: diverted autophagic flux, enhanced nuclear import, elevated necrosis and improved antitumor effects. Biomaterials. 2014; 40:12-22. DOI: 10.1016/j.biomaterials.2014.11.034. View

12.

Feng X, Chen L, Guo W, Zhang Y, Lai X, Shao L . Graphene oxide induces p62/SQSTM-dependent apoptosis through the impairment of autophagic flux and lysosomal dysfunction in PC12 cells. Acta Biomater. 2018; 81:278-292. DOI: 10.1016/j.actbio.2018.09.057. View

13.

Munson M, Ganley I . MTOR, PIK3C3, and autophagy: Signaling the beginning from the end. Autophagy. 2015; 11(12):2375-6. PMC: 4835211. DOI: 10.1080/15548627.2015.1106668. View

14.

Heras-Sandoval D, Perez-Rojas J, Hernandez-Damian J, Pedraza-Chaverri J . The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration. Cell Signal. 2014; 26(12):2694-701. DOI: 10.1016/j.cellsig.2014.08.019. View

15.

Wang C, Yu J, Miao D, Wu Z, Tan M, Tan L . Targeting the mTOR signaling network for Alzheimer's disease therapy. Mol Neurobiol. 2013; 49(1):120-35. DOI: 10.1007/s12035-013-8505-8. View

16.

Singh A, Kashyap M, Tripathi V, Singh S, Garg G, Rizvi S . Neuroprotection Through Rapamycin-Induced Activation of Autophagy and PI3K/Akt1/mTOR/CREB Signaling Against Amyloid-β-Induced Oxidative Stress, Synaptic/Neurotransmission Dysfunction, and Neurodegeneration in Adult Rats. Mol Neurobiol. 2016; 54(8):5815-5828. DOI: 10.1007/s12035-016-0129-3. View

17.

Caccamo A, Magri A, Medina D, Wisely E, Lopez-Aranda M, Silva A . mTOR regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies. Aging Cell. 2013; 12(3):370-80. PMC: 3655115. DOI: 10.1111/acel.12057. View

18.

Fan S, Zhang B, Luan P, Gu B, Wan Q, Huang X . PI3K/AKT/mTOR/p70S6K Pathway Is Involved in Aβ25-35-Induced Autophagy. Biomed Res Int. 2015; 2015:161020. PMC: 4637023. DOI: 10.1155/2015/161020. View

19.

Perluigi M, Pupo G, Tramutola A, Cini C, Coccia R, Barone E . Neuropathological role of PI3K/Akt/mTOR axis in Down syndrome brain. Biochim Biophys Acta. 2014; 1842(7):1144-53. PMC: 4062876. DOI: 10.1016/j.bbadis.2014.04.007. View

20.

Singh D, Herrera C, Singh B, Singh S, Singh R, Kumar R . Graphene oxide: An efficient material and recent approach for biotechnological and biomedical applications. Mater Sci Eng C Mater Biol Appl. 2018; 86:173-197. DOI: 10.1016/j.msec.2018.01.004. View